Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011).
Patrick K StrotmanTaylor J ReifStephanie A KliethermesJasmin K SandhuLukas M NystromPublished in: Journal of surgical oncology (2017)
The overall prognosis of dedifferentiated chondrosarcoma is poor with a 5-year overall survival of 18%. Patients with a primary tumor located in the chest wall had a better prognosis. Tumors larger than 8 cm, presence of metastases at diagnosis, and treatment without surgical resection were significant predictors of mortality.